Practical Geriatrics ›› 2023, Vol. 37 ›› Issue (7): 662-666.doi: 10.3969/j.issn.1003-9198.2023.07.005

Previous Articles     Next Articles

Effect of glycopyrrolate on pulmonary function and pulmonary shunt in elderly patients with lung cancer undergoing radical resection

YUAN Yi-dan, LIU Zeng, LU Xi-hua   

  1. Department of Anesthesiology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou 450008, China
  • Received:2022-08-29 Online:2023-07-20 Published:2023-07-24
  • Contact: LU Xi-hua, Email: hnlxh66@163.com

Abstract: Objective To observe the effect of glycopyrrolate on pulmonary function and pulmonary shunt in the elderly patients undergoing radical resection of lung cancer. Methods Ninety elderly patients undergoing radical resection of lung cancer were randomly divided into glycopyrrolate group (group G) and control group (group N), with 45 patients in each group. The patients in group G were intravenously injected with glycopyrrolate (5 μg/kg), while the patients in group N were intravenously injected with 0.9% sodium chloride 10 min before anesthesia induction. The hemodynamics of the patients were observed continuously at 6 time points, before anesthesia induction (T0), two lung ventilation for 15 min after endotracheal intubation (T1) and 15 min (T2), 30 min (T3), 40 min (T4), 50 min (T5) after one-lung ventilation. Airway resistance (Raw), pulmonary compliance (Comp) and peak airway pressure (Ppeak) were recorded at T1, T2, T3, T4 and T5. Arterial blood and internal carotid venous blood were collected at T1, T2, and T3 for blood gas analysis. PaO2 and PaCO2 were recorded, and the intrapulmonary shunt rate (Qs/Qt) was calculated. Results After one-lung ventilation, the level of PaO2 decreased, and the levels of Qs/Qt, PaCO2 increased at T2 and T3 (P<0.05); The levels of Raw and Ppeak increased at T2-T5 (P<0.05). Compared with group N, the level of Comp of group G was higher, and the level of Ppeak was lower at T3-T5, and the level of Qs/Qt was lower at T2 and T3 (P<0.05). Conclusions Intravenous injection of glycopyrrolate can dilate bronchus, reduce intrapulmonary shunt, improve lung compliance, protect lung function without influencing the hemodynamics in the elderly patients undergoing radical resection of lung cancer.

Key words: glycopyrrolate, pulmonary function, pulmonary shunt, aged

CLC Number: